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INTRODUCTION
Cervical cancer is the third most common cancer
in the world. It is the only cancer that can be
identified early thus making it able to be pre-
vented. Cervical cancer is the fourth cause of death
due to cancer in the world. In 2008, it estimated
that 530,232 women were diagnosed with cervical
cancer worldwide and 275,000 of them died.1 The
majority of cervical cancer (85%) occurred in
developing countries, including Indonesia. The
prevalence of women with cervical cancer in
Indonesia is fairly high; 40-45 new cases were
found daily with number of deaths reached 20-25
people while women at risk of cervical cancer was
48 millions.2 Data from health department
demonstrated that regions with the highest
Abstract
Objective: To determine the level of acceptance of self Human Papil-
loma Virus (HPV) examination and to compare the level of sensitiv-
ity and specificity of self HPV examination with Fluid Based Cytology
on precancerous cervical lesion and cervical cancer.
Methods: The analytical method used in this research was cross sec-
tional with purposive sampling. This study is conducted at Wahidin
Sudirohusodo Hospital and its affiliation from October 2014 to May
2015 with 101 subjects. The data measurement used self HPV ex-
amination tool and fluid based cytology kit. The data collected
through questionnaires before and after the examination. The labo-
ratory examination was carried out using the way of HPV Genotyp-
ing primary system (MY09/11) method Wl LTS-06, which is able to
detect 35 types of HPV viruses.
Results: A total of 101 subjects were involved in this study. The sub-
jects were divided into two groups: the abnormal and normal group
(n - 50/51). The acceptance level of self HPV examination was
62.37% (n = 63/101). Majority of subjects (88.21%) were ready to
repeat the same examination in the future. The level of sensitivity
and specificity for self HPV were (56% (95%CI (41.25 - 70.01%)) vs
98% (95%CI (89.55 - 99.95%)), p=<0.000001, while the level of sen-
sitivity and specificity for fluid based cytology were (40% (95%CI
(26.41 - 54.82%)) vs 98% (95%CI (89.35 - 99.95%)), p=0.000002.
Conclusion: HPV self-testing is very potential to be used as an al-
ternative method for cervical cancer screening.
[Indones J Obstet Gynecol 2017; 5-2: 114-119]
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Abstrak
Tujuan: Mengetahui tingkat penerimaan pemeriksaan HPV
Mandiri dan membandingkan tingkat sensitivitas dan spesifi-sitas pemeriksaan mandiri HPV dengan sitologi berbasis cairan,
pada lesi pre kanker derajat tinggi dan kanker serviks.
Metode: Penelitian merupakan analitik cross sectional secara pur-
posive sampling, single center di RS Wahidin Sudirohusodo dan Afilia-
sinya pada Bulan Oktober 2014-Mei 2015 berjumlah 101 responden.Pengukuran data menggunakan alat pemeriksaan HPV mandiri ser-
ta kit sitologi berbasis cairan. Pengumpulan data menggunakankuesioner sebelum dan setelah melakukan pemeriksaan. Pemeriksaan
laboratorium dilakukan dengan menggunakan cara HPV Genotyping
sistem primer (MY09/ll) metode WI LTS-06, mampu mendeteksi 35tipe virus HPV.
Hasil: Keseluruhan responden berjumlah 101 orang, terbagi men-jadi kelompok abnormal/normal (n=50/51). Tingkat penerimaan
pemeriksaan HPV mandiri sebesar 62,37% (n=63/101). Sebagianbesar responden (88,21%) bersedia mengulangi pemeriksaan se-
rupa di masa mendatang. Tingkat sensitivitas dan spesifisitas yang
didapatkan untuk HPV Mandiri (56% (95%CI (41,26 - 70,01%)) vs98% (95%CI (89,55 - 99,95%)), p=<0,000001, sedangkan tingkat
sensitivitas dan spesifisitas untuk sitologi berbasis cairan (40%
(95%CI (26,41 - 54,82%)) vs 98% (95%CI (89,35 - 99,95%)),p=0,000002.
Kesimpulan: Pemeriksaan HPV mandiri ini sangat potensial untuk
dijadikan metode pemeriksaan alternatif untuk pemeriksaan skrining
kanker serviks.
[Maj Obstet Ginekol Indones 2017; 5-2: 114-119]
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number of cervical and breast cancer were
Makassar, district of Gowa, Wajo, Bone, and North
Luwu. In 2009, it was found that 97 cervical cancer
cases was in hospital and 177 cases was in primary
health care.3
Human Papilloma Virus (HPV) infection is a
significant event for the occurrence of cervical
cancer. It is estimated that 50-80% of sexually
active women will be infected by HPV in their life
and approximately 80% will be infection-free in 2
years and will not cause cancer. Persistent HPV
infection is one of the predispositions of dysplasia
and cervical cancer. The course of HPV infection
developing into cervical cancer may take up to
10-20 years. HPV infection process which later
becomes precancerous is mostly asymptomatic.4-6
Cytology examination has become cervical
cancer screening standard for more than 50 years.
This examination evaluates cell morfology
abnormalities from cervical epithelial specimen.7
This examination often results in false negative due
to inadequate sample and poor procedure
standard. Liquid-based examination may improve
this disadvantage. The high false negative result of
this examination leads to reevaluation in the
interval period of time.8-10
HPV DNA examination has the advantage of
very high negative predictive value, even towards
adenocarcinoma precursor.11 Human papilloma
virus has a high sensitivity in detecting high degree
precancer lesion and has high positive predictive
value.12 The effectiveness of this cervical cancer
screening programme may be increased by the use
of HPV self examination. According to a study in
Netherlands, an HPV self examination tool, Evalyn
brush, has a sensitivity and specificity of 81.5%
and 66.4%, respectively.13 Efforts on early detec-
tion in high risk women are organized into a
screening programme or an opportunistic screen-
ing. Management and early detection of precancer
lesions are ’see and treat’ programme and his-
topathology-based-diagnosis.
A good screening examination should be acu-
rate, highly reproducible, cheap, easy to use, easy
to monitor, highly accepted, and safe.14
Examination to be used should have been
through long period of evaluation and tested in real
life. Clinical application of the proposed HPV DNA
examination may be as single primary screening
instrument or combination with cytology and
monitoring women with precancer lesion who
has received treatment in order to predict the suc-
cess of therapy.
High sensitivity means that HPV examination
also has high negative predictive value. Negative
result of examination may prolong the need to
repeat the cervical cancer screening up to 5-8
years.13 Cytologic examination is often constrained
by the lack of infrastructure, particularly in
developing countries. Alliance for cervical cancer
prevention seeks for alternatives other than
cytologic examination, such as acetic acid visual
inspection and HPV DNA test. According to a study
conducted by Qiao et al, HPV DNA examination and
liquid based cytology had higher sensitivities than
acetic acid visual inspection.12
Self examination of vaginal or cervical specimen
sampling has developed in recent years. Self exami-
nation derived from vaginal specimen has the in-
ability of the specimen for cytologic examination.
However, vaginal specimens are very suitable for
HPV examination sample because the result do not
significantly differ from those of liquid based
cytology or cervical specimen. In self examination,
women would collected their own specimen
sample using several tools including brush,
tampon, and vagina rinse instrument. Some
research showed that self vaginal specimen
sampling was sufficient for laboratory analysis,
both delivered through liquid or dry media.15
The ability to detect high risk HPV from self HPV
examination or liquid based cytology examination
shows no significant differences. This explains that
there is no difference in the ability to detect HPV
between self examination and examination by
paramedics. One advantage of self examination is
it does not need paramedics to be performed and
ensure privacy. Based on user experiences, this
examination is considered easy to use. As cervical
cancer screening tool, this tool will improve the
outreach of screening on women who has not or
rarely checked. Most cervical cancer are found in
women who never or rarely check.16-18 We aimed
to know the level of acceptance of HPV self
examination and compare the sensitivity and
specificity of HPV self examination and liquid based
examination on high degree pre cancer lesion and
cervical cancer.
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METHODS
A cross sectional study design was used. This study
was conducted at several teaching hospitals
affiliated with the department of Obstetrics and
Gynecology, Faculty of Medicine, Hasanuddin
University, Makassar from October 2014 until
May 2015.
The subjects were women who experienced
spontaneous abortion and normal term delivery
in several teaching hospitals of Obstetric and
Gynecology Department Universitas Hasanuddin
Faculty of Medicine in Makassar. Samples were
obtained from blood samples of the mothers who
met the inclusion criteria.
Method of collecting data
Samples were selected based on an assessment of
researchers that met the eligible inclusion criteria
with purposive sampling method between 2 group.
Data were obtained by self HPV examination tool,
liquid based cytology kit, and before and after
examination questionnaire. Laboratory test was
done by QI LTS-06 method of primary system
(MY09/11) HPV Genotyping which was able to
detect 35 types of HPV.
Data analysis
Data were analyzed using SPSS. Diagnostic 2x2
table test is used to determine the capability of
each tool.
RESULTS
A total of 101 subjects were involved in this study.
The subjects were divided into abnormal/normal
group (n=50/51). The most age group percentage
was the age group of 40-49 year, 40.58%
(n=41/101). The respondent was mostly at the
education level of high school/on the equal degree,
54.45% (n=50/101). Majority of the subjects were
housewives, 73.26% (n=74/101). There were 23
subjects who work as private or civil employees.
Most of the subjects was multiparous, 88.12%
(n=89/101), did not use contraception, 57.42%
(n=27/101). Majority of respondents complained
of leucorrhoea, 45.54% (n=46/101), 56.5% was
abnormal and 43.5% was normal. Majority of the
normal population had no complain (n=24/
51.47%) before the examination, whereas majority
of the abnormal group complained of leucorrhoea
(26/50.52%). Majority of the respondents did not
know about cervical cancer screening, 79.2%
(n=80/101). The major result of Pap smear test of
the normal and abnormal group were folicular
cervicitis [(n=34/51, 66.67%) and (23/50, 46%),
respectively].
Acceptance rate of self HPV examination was
62.37% (n=63/101). As many as 37.62% (n=38/
101) of the respondent suggested the examination
was difficult/could not do the examination by her-
self because it was difficult to recognize or to
insert the instrument (n=27/38, 71.05%). 92 sub-
jects (92/101, 91.01%) did not find difficulties to
perform the examination, 54.3% of which was ab-
normal and 45.7% was normal. However there
was 5 subjects who reported pain, 1 subject
reported bleeding, 2 subjects failed to used the
tool. Of 89 subjects (n = 89/101), 88.12% would
repeat HPV testing self-sampling and 12 subjects
(n = 12/101) 11.8% would not repeat this test.
From those who were willing to repeat the exami-
nation in the future because it was easy to use (n
= 75/101) 84.23%.
Half of our subjects were highly educated. 64%
stated that this tool were ease to use. 84 subjects
did not know anything about cancer screening,
66.2% managed to use this tool easily.
The sensitivity and specificity were obtained for
HPV Self sample collection test is 56% (95% CI
(41.25 to 70.01%)) vs 98% (95% CI (89.55 to
99.95%)), with positive predictive value of 68,
25%, 95% CI (22.75 to 96.43%); 96.73% negative
predictive value, 95% CI (20.9 to 99.28%); Accu-
racy of 0.78, 95% CI (0.68 to 0.85); Compliance
Test Kappa 0.543, 95% CI (0.365 to 0.72); p
<0.000001.
While the sensitivity and specificity for liquid-
based cytology is 40% (95% CI (26.41 to 54.82%))
vs 98% (95% CI (89.35 to 99.95%)); Positive pre-
dictive value of 60%, 95% CI (13.54 to 93.35%,;
95.6% negative predictive value, 95% CI (89.32 to
98.74%); Accuracy 0.69, 95% CI (0.59 to 0.78); test
the suitability of Kappa = 0.38, 95% CI (0.22 to
0.54); p = 0.000002.
The results of diagnostic test liquid-based cytol-
ogy (LBC) in cervical cancer and precancerous le-
sions of the 16 samples were defined as abnormal
by 76.19% who tested positive on HPV testing in-
dependently (HPV-SSC) and 23.8% expressed
negative. While 79 normal results showed that
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83.54% had negative on HPV testing inde-
pendently (HPV-SSC) and 16.45% tested positive.
The results of the suitability test results of both
tests Kappa value = 0.524 95% CI (0.28 to .768).
All HPV virus detected in the abnormal group
were the high-risk HPV types, such as type 16, 18,
31, 33, 45, 51, 53. In the normal group, we obtained
one sample who was detected as low risk HPV
type.
DISCUSSION
This study evaluated the use of HPV self sample
collection test in Makassar as a new diagnostic tool.
Our evaluation was done by comparing the his-
topathology, thus we may determine the ability of
each new diagnostic screening tool. The Accep-
tance rate was fairly, good (62.37%). This finding
is consistent with several studies (73%17; 87%18;
77.1%)19.
Approximately 91.01% of the subjects did not
have difficulties in doing the examination and
88.12% of the subjects were willing to repeat a
similar examination in the future. Some parts of
the tools fell apart and left in the vagina were the
short comings of the tool integrity and expected to
have an impact on the design and improvement
of educational plan using the tool. Subjects who ad-
mitted to have difficulties to perform self-HPV test-
ing said that there was no denial of the usage of
these tools which we were considered suitable
with our society culture or religion. HPV testing
self-denial rate was found relatively high in all age
groups (30 to 58.8%), and employment (25 to
41.9%). This result is understandable because HPV
testing is a new independent examination. We may
increase the acceptance rate by considering on
education and make this as a routine examination.
Cytology has become gold standard examination
for cervical cancer screening more than last 50
years. This examination evaluates the presence
of morphological abnormalities from epithelial cer-
vical specimens. Conventional cytological examina-
tion has a sensitivity of 30-87% and specificity of
86-100% for detecting high-grade precancerous
lesions. Smear results are often unsatisfactory with
high false negative value. Later, liquid-based
cytology was developed. Its sensitivity and
specificity are 80% and 98%. The number of
samples found unsatisfactory on LBC decreased
11.45%.20 Several studies found the level of
sensitivity of liquid-based cytology 13% higher
than the conventional Pap smear test. These results
suggested that liquid-based cytology had a higher
level of sensitivity and specificity levels lower than
Pap smear test.20 On the use of routine screening
cytological examination only have a level of
sensitivity ranged from 47-62% and a specificity
ranged from 60-95%. A meta-analysis of the results
revealed similar results to those obtained in this
study, the rate reaches 97-100% specificity and
sensitivity is only 29-56%.21 However, these
results still show a sensitivity level much lower
than the results of research in general. The new
technology for cervical cancer (NTCC) and
Netherland Thin Prep versus Conventional
Cytology (NETHCON) indicates that there is no
difference in the detection capability CIN2 / 3 on
both methods.22
The level of sensitivity of HPV DNA tests for
the detection of CIN2 + was better than cytology
(94% vs 65%).21,23 In this study, the sensitivity of
self-HPV testing is higher than liquid-based
cytology with a difference of 16%, the specificity
found similar on both tests. A study in China
demonstrated that self-HPV testing had a sensiti-
vity of 86.2% and a specificity of 80.7% while
liquid-based cytology had lower sensitivity in
detecting CIN2.24 High risk HPV DNA can be
identified 99.7% of cervical cancers and 95% of
high-grade precancerous lesions.25,26 The results of
this study showed different results that only high
risk HPV types identified (n = 16/32) 50% of
cervical cancers and (n = 6/19) 31.57% of high-
grade precancerous lesions. All types of HPV
detected in the abnormal group were high risk
HPV types. HPV DNA PCR method used in this
study was GMP09 / 11. The use of PCR method has
been shown to have higher sensitivity for detecting
high-risk HPV compared to HC2. According to
the results of one RCT, amplification method
GPM09 / 11 had very low sensitivity level, which
accounted for 49%.26 Therefore, our decision to
use similar method could potentially cause low
levels of sensitivity.
The usage of certain fixation media and speci-
men processing of cells contained in the media
might influence our results. This might be due to
the lack of uniformity filtration process and the
possibility of not drawing a specimen of cells in the
remaining media.20 Methods of sample collection
for HPV testing can be done through swab, brush,
tampon or lavage. The various methods mentioned
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showed 78-81% sensitivity rate for the swab or
brush, 67-94% for tampons, and <81% for
lavage.27 The collection method used in this study
is brush, and it’s likely affect the validity of the
test. The prevalence of high-risk HPV 62.3% (95%
CI: 53.7 to 70.2) was detected in the examination
without media fixation and 56.2% (95% CI: 47.6
to 64.4) in the use of media fixation.28 Sample
collection without using fixation was likely to
affect the results of our study.
Population and national study which evaluate
the level of acceptance, economic impact, the accu-
racy and precision tools, awareness, adherence
screening and suitability level of HPV examination
results need to be conducted before using this HPV
testing as a screening method in institutions.27
This study has not been able to ascertain with
certainty the validity of the examination, however,
the examination is potential to be used as an
alternative method of screening.
CONCLUSIONS
Cervical cancer has a long course of the disease,
yet it can be prevented. Self-testing of HPV the
latest potential modality for cervical cancer
screening that corresponds to the cultural,
economic, human resources and geographics
in Indonesia. 
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